CIK 0000811641
- Non-accelerated filer
- Smaller reporting company
IMMUCELL CORP /DE/
Sign in to watch- Ticker
- ICCC
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010382980
- Phone
- +1 207-878-2770
- Business address
- 56 EVERGREEN DR, PORTLAND, ME, 04103
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 34 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-16 | Rosgen Steven T. Director | Grant or award · Non Qualified Stock Options (Right to buy) | +10,000 | 10,000 | ||
| 2024-09-20 | Rosgen Steven T. Director | Grant or award · Non Qualified Stock Options (Right to buy) | +10,000 | $3.60 | $36K | 10,000 |
| 2022-12-15 | Rosgen Steven T. Director | Grant or award · Non Qualified Stock Options (Right to buy) | +10,000 | $6.52 | $65K | 10,000 |
| 2021-06-17 | Rosgen Steven T. Director | Grant or award · Incentive Stock Options (Right to buy) | +10,000 | $10.04 | $100K | 10,000 |
| 2018-03-19 | Rosgen Steven T. Director | Grant or award · Incentive Stock Options (Right to buy) | +15,000 | $7.08 | $106K | 15,000 |
Page 1 of 1 · 5 trades